Literature DB >> 33678581

Survival prediction after upfront surgery in patients with pancreatic ductal adenocarcinoma: Radiomic, clinic-pathologic and body composition analysis.

Hongyuan Shi1, Yun Wei1, Shenhao Cheng1, Zipeng Lu2, Kai Zhang2, Kuirong Jiang3, Qing Xu4.   

Abstract

OBJECTIVE: To investigate the value of radiomic features at contrast-enhanced CT integrated with clinic-pathologic features and body composition measures for predicting survival after upfront surgery in patients with pancreatic ductal adenocarcinoma (PDAC).
METHODS: Two hundred and ninety-nine patients with PDAC who underwent surgical resection were included and allocated to training set (210 patients) and validation set (89 patients). The radiomics signature for predicting survival was constructed by using the least absolute shrinkage and selection operator Cox regression. Multivariable Cox regression analysis was used to construct a radiomics model based on radiomics signature, clinic-pathologic features and body composition measures. A clinical model without radiomics signature was also developed. Model performance was analyzed by Harrell's concordance index (C-index) and time-independent receiver operating characteristic (ROC) analysis. The Kaplan-Meier (KM) method was used for survival analysis.
RESULTS: Five independent variables were selected for the radiomics model: radiomics signature, carbohydrate antigen 19-9, skeletal muscle index, histologic grade and postoperative chemotherapy. The radiomics-based model provided better predictive performance (C-index = 0.73; all p < 0.05) than the clinical model without radiomics signature and American Joint Committee on Cancer (AJCC) TNM staging system. Patients were stratified as high-risk and low-risk group by the radiomics model. The KM analysis showed a significant difference between two groups (p < 0.05).
CONCLUSION: The radiovdmics-based model integrating with clinic-pathologic features and body composition measures could predict survival after surgical resection in PDAC patients.
Copyright © 2021 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Multidetector computed tomography; Pancreatic neoplasms; Radiomics; Survival

Mesh:

Year:  2021        PMID: 33678581     DOI: 10.1016/j.pan.2021.02.009

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  3 in total

1.  A novel preoperative MRI-based radiomics nomogram outperforms traditional models for prognostic prediction in pancreatic ductal adenocarcinoma.

Authors:  Hui Qiu; Muchen Xu; Yan Wang; Xin Wen; Xueting Chen; Wanming Liu; Nie Zhang; Xin Ding; Longzhen Zhang
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

Review 2.  Using Quantitative Imaging for Personalized Medicine in Pancreatic Cancer: A Review of Radiomics and Deep Learning Applications.

Authors:  Kiersten Preuss; Nate Thach; Xiaoying Liang; Michael Baine; Justin Chen; Chi Zhang; Huijing Du; Hongfeng Yu; Chi Lin; Michael A Hollingsworth; Dandan Zheng
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

Review 3.  Setting the Research Agenda for Clinical Artificial Intelligence in Pancreatic Adenocarcinoma Imaging.

Authors:  Megan Schuurmans; Natália Alves; Pierpaolo Vendittelli; Henkjan Huisman; John Hermans
Journal:  Cancers (Basel)       Date:  2022-07-19       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.